HSV-1 amplicon vectors - Simplicity and versatility

Molecular Therapy

Volumn 2, Issue 1, 2000, Pages 9-15

  Sena Esteves, Miguel ^a   Saeki, Yoshinaga ^b   Fraefel, Cornel ^c   Breakefield, Xandra O ^d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 1;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS 1; HUMAN; METHODOLOGY; PHYSIOLOGY; RETROVIRUS; REVIEW; TRANSGENE;

ADENOVIRIDAE; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; RETROVIRIDAE; TRANSGENES;

EID: 0034219104     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0096     Document Type: Review

References (65)

1. Breakefield, X. O., Kramm, C. M., Chiocca, E. A., and Pechan, P. A. (1995). Herpes simplex virus vectors for tumor therapy. In The Internet Book of Gene Therapy: Cancer Gene Therapeutics (R. E. Sobol and K. J. Scanlon, Eds.), pp. 41-56, Appleton and Lange, Stamford, CT.
2. Glorioso, J. C., DeLuca, N. A., and Fink, D. J. (1995). Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol. 49: 675-710.
3. Jacobs, A., Breakefield, X. O., and Fraefel, C. (1999). HSV-1 based vectors for gene therapy of neurological diseases and brain tumors: Part II. Neoplasia 1: 402-416.
4. Spaete, R. R., and Frenkel, N. (1985). The herpes simplex virus amplicon: Analyses of cis-acting replication functions. Proc. Natl. Acad. Sci. USA 82: 694-698.
5. Spaete, R. R., and Frenkel, N. (1982). The herpes simplex virus amplicon: A new eukaryotic defective-virus cloning-amplifying vector. Cell 30: 295-304.
6. Fraefel, C., et al. (1997). Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol. Med. 3: 813-825.
7. Costantini, L. C., Jacoby, D. R., Wang, S., Fraefel, C., Breakefield, X. O., and Isacson, O. (1999). Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Hum. Gene Ther. 10: 2481-2494.
8. Suter, M., et al. (1999). BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 96: 12697-12702.
9. Geller, A. I., and Breakefield, X. O. (1988). A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science 241: 1667-1669.
10. Ho, D. Y., et al. (1995). Herpes simplex virus vector system: Analysis of its in vivo and in vitro cytopathic effects. J. Neurosci. Methods 57: 205-215.
11. Johnson, P. A., Miyanohara, A., Levine, F., Cahill, T., and Friedmann, T. (1992). Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66: 2952-2965.
12. Wood, M. J., Byrnes, A. P., Pfaff, D. W., Rabkin, S. D., and Charlton, H. M. (1994). Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther. 1: 283-291.
13. Fraefel, C., et al. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70: 7190-7197.
14. Saeki, Y., et al. (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther. 9: 2787-2794.
15. Stavropoulos, T. A., and Strathdee, C. A. (1998). An enhanced packaging system for helper-dependent herpes simplex virus vectors. J. Virol. 72: 7137-7143.
16. Ho, D. Y., Mocarski, E. S., and Sapolsky, R. M. (1993). Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc. Natl. Acad. Sci. USA 90: 3655-3659.
17. Kaplitt, M. G., Kwong, A. D., Kleopoulos, S. P., Mobbs, C. V., Rabkin, S. D., and Pfaff, D. W. (1994). Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc. Natl. Acad. Sci. USA 91: 8979-8983.
18. Oh, Y. J., Moffat, M., Wong, S., Ullrey, D., Geller, A. I., and O'Malley, K. L. (1996). A herpes simplex virus-1 vector containing the rat tyrosine hydroxylase promoter directs cell type-specific expression of beta-galactosidase in cultured rat peripheral neurons. Brain Res. Mol. Brain Res. 35: 227-236.
19. Song, S., et al. (1997). An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J. Neurochem. 68: 1792-1803.
20. Jones, P. L., et al. (1998). Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19: 187-191.
21. Yates, J. L., Warren, N., and Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815.
22. Wang, S., and Vos, J. M. (1996). A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J. Virol. 70: 8422-8430.
23. Balague, C., Kalla, M., and Zhang, W. W. (1997). Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71: 3299-3306.
24. Pieroni, L., et al. (1998). Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 249: 249-259.
25. Johnston, K. M., et al. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8: 359-370.
26. Sena-Esteves, M., Saeki, Y., Camp, S. M., Chiocca, E. A., and Breakefield, X. O. (1999). Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons. J. Virol. 73: 10426-10439.
27. Lu, B., and Federoff, H. J. (1995). Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum. Gene Ther. 6: 419-428.
28. Ho, D. Y., McLaughlin, J. R., and Sapolsky, R. M. (1996). Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Brain Res. Mol. Brain Res. 41: 200-209.
29. Fotaki, M. E., Pink, J. R., and Mous, J. (1997). Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer. Gene Ther. 4: 901-908.
30. Rossi, F. M., et al. (1998). Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat. Genet. 20: 389-393.
31. Freundlieb, S., Schirra-Muller, C., and Bujard, H. (1999). A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J. Gene Med. 1: 4-12.
32. Logvinoff, C., and Epstein, A. L. (2000). Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase. Virology 267: 102-110.
33. Kwong, A. D., and Frenkel, N. (1985). The herpes simplex virus amplicon. IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes. Virology 142: 421-425.
34. Geller, A. I., Keyomarsi, K., Bryan, J., and Pardee, A. B. (1990). An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology. Proc. Natl. Acad. Sci. USA 87: 8950-8954.
35. Lim, F., et al. (1996). Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques 20: 460-469.
36. Cunningham, C., and Davison, A. J. (1993). A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197: 116-124.
37. Wang, X., Zhang, G. R., Yang, T., Zhang, W., and Geller, A. I. (2000). Fifty-one kilobase HSV-1 plasmid vector can be packaged using a helper virus-free system and supports expression in the rat brain. Biotechniques 28: 102-107.
38. Saeki, Y., and Fraefel, C. (2000). Gene transfer using helper virus-free HSV-1 amplicon and hybrid amplicon vectors. In Viral Vectors in Gene Therapy and Basic Research (A. Cid-Arregui and A. G. Carranca, Eds.), Eaton Publishing, Natick, MA.
39. Mandel, R. J., Rendahl, K. G., Spratt, S. K., Snyder, R. O., Cohen, L. K., and Leff, S. E. (1998). Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J. Neurosci. 18: 4271-4284.
40. Leff, S. E., Spratt, S. K., Snyder, R. O., and Mandel, R. J. (1999). Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease. Neuroscience 92: 185-196.
41. Conway, J. E., Zolotukhin, S., Muzyczka, N., Hayward, G. S., and Byrne, B. J. (1997). Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol. 71: 8780-8789.
42. Zhang, X., et al. (1999). High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H. Hum. Gene Ther. 10: 2527-2537.
43. Savard, N., Cosset, F. L., and Epstein, A. L. (1997). Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retro-virus vectors. J. Virol. 71: 4111-4117.
44. Anderson, D. B., Laquerre, S., Goins, W. F., Cohen, J. B., and Glorioso, J. C. (2000). Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J. Virol. 74: 2481-2487.
45. Laquerre, S., Argnani, R., Anderson, D. B., Zucchini, S., Manservigi, R., and Glorioso, J. C. (1998). Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 72: 6119-6130.
46. Montgomery, R. I., Warner, M. S., Lum, B. J., and Spear, P. G. (1996). Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427-436.
47. Whitbeck, J. C., et al. (1997). Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J. Virol. 71: 6083-6093.
48. Fuller, A. O., and Lee, W. C. (1992). Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J. Virol. 66: 5002-5012.
49. Turner, A., Bruun, B., Minson, T., and Browne, H. (1998). Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J. Virol. 72: 873-875.
50. Laquerre, S., Anderson, D. B., Stolz, D. B., and Glorioso, J. C. (1998). Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. J. Virol. 72: 9683-9697.
51. Spear, M. A., Herrlinger, U., Rainov, N., Pechan, P., Weissleder, R., and Breakefield, X. O. (1998). Targeting gene therapy vectors to CNS malignancies. J. Neurovirol. 4: 133-147.
52. Roizman, B., and Sears, A. E. (1996). Herpes simplex viruses and their replication. In Fields Virology (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), pp. 2231-2296, Lippincott-Raven Publishers, Philadelphia.
53. Steven, A. C., and Spear, P. G. (1997). Herpesvirus capsid assembly and envelopment. In Structural Biology of Viruses (W. Chiu, R. Burnett, and R. Garcea, Eds.), pp. 312-351, Oxford Univ. Press, New York.
54. Read, G. S., and Frenkel, N. (1983). Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides. J. Virol. 46: 498-512.
55. Friedman, A. D., Triezenberg, S. J., and McKnight, S. L. (1988). Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature 335: 452-454.
56. Weinheimer, S. P., Boyd, B. A., Durham, S. K., Resnick, J. L., and O'Boyle, D. R. d. (1992). Deletion of the VP16 open reading frame of herpes simplex virus type 1. J. Virol. 66: 258-269.
57. Elliott, G., and O'Hare, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88: 223-233.
58. Dilber, M. S., et al. (1999). Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. 6: 12-21.
59. Ivics, Z., Hackett, P. B., Plasterk, R. H., and Izsvak, Z. (1997). Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510.
60. Thyagarajan, B., Guimaraes, M. J., Groth, A. C., and Calos, M. P. (2000). Mammalian genomes contain active recombinase recognition sites. Gene 244: 47-54.
61. Rinaldi, A., Marshall, K. R., and Preston, C. M. (1999). A non-cytotoxic herpes simplex virus vector which expresses Cre recombinase directs efficient site specific recombination. Virus Res. 65: 11-20.
62. Ikeno, M., et al. (1998). Construction of YAC-based mammalian artificial chromosomes. Nat. Biotechnol. 16: 431-439.
63. du Sart, D., et al. (1997). A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA. Nat. Genet. 16: 144-153.
64. Barry, A. E., Howman, E. V., Cancilla, M. R., Saffery, R., and Choo, K. H. (1999). Sequence analysis of an 80 kb human neocentromere. Hum. Mol. Genet. 8: 217-227.
65. Nielsen, T. O., Cossons, N. H., Zannis-Hadjopoulos, M., and Price, G. B. (2000). Circular YAC vectors containing short mammalian origin sequences are maintained under selection as HeLa episomes. J. Cell. Biochem. 76: 674-685.